EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy

Elena R Rhymes, Rebecca L Simkin, Ji Qu, David Villarroel-Campos, Sunaina Surana, Yao Tong, Ryan Shapiro, Robert W Burgess, Xiang-Lei Yang, Giampietro Schiavo, James N Sleigh

Neurobiology of Disease · 2024

DOI: 10.1016/j.nbd.2024.106501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Elena R Rhymes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, Queen Square Institute of Neurology, University College London…. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Brain-Derived Neurotrophic Factor, Axonal Transport, Disease Models, Animal. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot-Marie-Tooth disease (CMT) is a genetic peripheral neuropathy caused by mutations in many functionally diverse genes. The aminoacyl-tRNA synthetase (ARS) enzymes, which transfer amino acids to partner tRNAs for protein synthesis, represent the largest protein family genetically linked to CMT aetiology, suggesting pathomechanistic commonalities. Dominant intermediate CMT type C (DI-CMTC) is caused by YARS1 mutations driving a toxic gain-of-function in the encoded tyrosyl-tRNA synthetase (TyrRS), which is mediated by exposure of consensus neomorphic surfaces through conformational changes of the mutant protein. In this study, we first showed that human DI-CMTC-causing TyrRSE196K mis-interacts with the extracellular domain of the BDNF receptor TrkB, an aberrant association we have previously characterised for several mutant glycyl-tRNA synthetases linked to CMT type 2D (CMT2D). We then performed temporal neuromuscular assessments of YarsE196K mice modelling DI-CMT. We determined that YarsE196K homozygotes display a selective, age-dependent impairment in in vivo axonal transport of neurotrophin-containing signalling endosomes, phenocopying CMT2D mice. This impairment is replicated by injection of recombinant TyrRSE196K, but not TyrRSWT, into muscles of wild-type mice. Augmenting BDNF in DI-CMTC muscles, through injection of recombinant protein or muscle-specific gene therapy, resulted in complete axonal transport correction. Therefore, this work identifies a non-cell autonomous pathomechanism common to ARS-related neuropathies, and highlights the potential of boosting BDNF levels in muscles as a therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseBrain-Derived Neurotrophic FactorAxonal TransportDisease Models, AnimalAnimalsMiceTyrosine-tRNA LigaseHumansMice, TransgenicMuscle, SkeletalReceptor, trkBMutation

Stichwörter der Autor:innen

Aminoacyl-tRNA synthetase (ARS)Charcot-Marie-tooth disease (CMT)Intravital imagingMotor neuronNeuromuscular junction (NMJ)Neurotrophic factorsNeurotrophinsPeripheral neuropathyTrk receptorsYARS1

Substanzen

Brain-Derived Neurotrophic FactorTyrosine-tRNA LigaseBdnf protein, mouseReceptor, trkB

Autor:innen und Institutionen

  • Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Department of Neuromuscular Diseases and UCL Queen Square Motor Neuron Disease Centre, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK; UK Dementia Research Institute at University Co…
  • Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • The Jackson Laboratory, Bar Harbor, ME 04609, USA.

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • Wellcome Trust
  • Medical Research Council
  • UK Dementia Research Institute
  • NIH
  • Human Frontier Science Program
  • Rosetrees Trust

Zitieren

APA

Rhymes, E. R., Simkin, R. L., Qu, J., Villarroel-Campos, D., Surana, S., Tong, Y., Shapiro, R., Burgess, R. W., Yang, X. L., Schiavo, G., & Sleigh, J. N. (2024). Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106501

Vancouver

Rhymes ER, Simkin RL, Qu J, Villarroel-Campos D, Surana S, Tong Y, et al. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106501

BibTeX
@article{Rhymes2024,
  author = {Rhymes, Elena R and Simkin, Rebecca L and Qu, Ji and Villarroel-Campos, David and Surana, Sunaina and Tong, Yao and Shapiro, Ryan and Burgess, Robert W and Yang, Xiang-Lei and Schiavo, Giampietro and Sleigh, James N},
  title = {Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy},
  journal = {Neurobiology of Disease},
  year = {2024},
  doi = {10.1016/j.nbd.2024.106501}
}
Kostenlos starten →